4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide

C136H138Cl2N36O20S2 — CID 162179916

IUPAC4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide
SMILESCOc1cc2nc(-c3[nH]ncc3NC(=O)C3CCC(N)CC3)[nH]c2cc1OC.COc1cc2nc(-c3[nH]ncc3NC(=O)CS(=O)(=O)c3ccc(Cl)cc3)[nH]c2cc1OC.COc1cc2nc(-c3[nH]ncc3NC(=O)c3cc(CN4CCOCC4)c(C)o3)[nH]c2cc1OC.COc1ccc(C(C)(C)C)cc1C(=O)Nc1cn[nH]c1-c1nc2ccccc2[nH]1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cc(-c2ccccc2)no1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cccnc1Sc1ccc(Cl)cc1
InChIInChI=1S/C27H24ClN7O2S.C25H23N7O3.C23H26N6O5.C22H23N5O2.C20H18ClN5O5S.C19H24N6O3/c28-18-4-6-19(7-5-18)38-27-20(2-1-9-29-27)26(36)33-23-15-30-34-24(23)25-31-21-8-3-17(14-22(21)32-25)16-35-10-12-37-13-11-35;33-25(22-13-19(31-35-22)17-4-2-1-3-5-17)29-21-14-26-30-23(21)24-27-18-7-6-16(12-20(18)28-24)15-32-8-10-34-11-9-32;1-13-14(12-29-4-6-33-7-5-29)8-20(34-13)23(30)27-17-11-24-28-21(17)22-25-15-9-18(31-2)19(32-3)10-16(15)26-22;1-22(2,3)13-9-10-18(29-4)14(11-13)21(28)26-17-12-23-27-19(17)20-24-15-7-5-6-8-16(15)25-20;1-30-16-7-13-14(8-17(16)31-2)25-20(24-13)19-15(9-22-26-19)23-18(27)10-32(28,29)12-5-3-11(21)4-6-12;1-27-15-7-12-13(8-16(15)28-2)23-18(22-12)17-14(9-21-25-17)24-19(26)10-3-5-11(20)6-4-10/h1-9,14-15H,10-13,16H2,(H,30,34)(H,31,32)(H,33,36);1-7,12-14H,8-11,15H2,(H,26,30)(H,27,28)(H,29,33);8-11H,4-7,12H2,1-3H3,(H,24,28)(H,25,26)(H,27,30);5-12H,1-4H3,(H,23,27)(H,24,25)(H,26,28);3-9H,10H2,1-2H3,(H,22,26)(H,23,27)(H,24,25);7-11H,3-6,20H2,1-2H3,(H,21,25)(H,22,23)(H,24,26)
InChIKeyZOWQGJPQMWCEQY-UHFFFAOYSA-N
MW2731.87 g/mol
LogP21.86
Rot. Bonds36

About 4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide

4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide (PubChem CID 162179916) has the molecular formula C136H138Cl2N36O20S2 and a molecular weight of 2731.87 g/mol. Its IUPAC name is 4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide.

Molecular Properties

Compound Name4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide
PubChem CID162179916
Molecular FormulaC136H138Cl2N36O20S2
Molecular Weight2731.87 g/mol
Exact Mass2728.97
IUPAC Name4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide
SMILESCOc1cc2nc(-c3[nH]ncc3NC(=O)C3CCC(N)CC3)[nH]c2cc1OC.COc1cc2nc(-c3[nH]ncc3NC(=O)CS(=O)(=O)c3ccc(Cl)cc3)[nH]c2cc1OC.COc1cc2nc(-c3[nH]ncc3NC(=O)c3cc(CN4CCOCC4)c(C)o3)[nH]c2cc1OC.COc1ccc(C(C)(C)C)cc1C(=O)Nc1cn[nH]c1-c1nc2ccccc2[nH]1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cc(-c2ccccc2)no1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cccnc1Sc1ccc(Cl)cc1
InChIInChI=1S/C27H24ClN7O2S.C25H23N7O3.C23H26N6O5.C22H23N5O2.C20H18ClN5O5S.C19H24N6O3/c28-18-4-6-19(7-5-18)38-27-20(2-1-9-29-27)26(36)33-23-15-30-34-24(23)25-31-21-8-3-17(14-22(21)32-25)16-35-10-12-37-13-11-35;33-25(22-13-19(31-35-22)17-4-2-1-3-5-17)29-21-14-26-30-23(21)24-27-18-7-6-16(12-20(18)28-24)15-32-8-10-34-11-9-32;1-13-14(12-29-4-6-33-7-5-29)8-20(34-13)23(30)27-17-11-24-28-21(17)22-25-15-9-18(31-2)19(32-3)10-16(15)26-22;1-22(2,3)13-9-10-18(29-4)14(11-13)21(28)26-17-12-23-27-19(17)20-24-15-7-5-6-8-16(15)25-20;1-30-16-7-13-14(8-17(16)31-2)25-20(24-13)19-15(9-22-26-19)23-18(27)10-32(28,29)12-5-3-11(21)4-6-12;1-27-15-7-12-13(8-16(15)28-2)23-18(22-12)17-14(9-21-25-17)24-19(26)10-3-5-11(20)6-4-10/h1-9,14-15H,10-13,16H2,(H,30,34)(H,31,32)(H,33,36);1-7,12-14H,8-11,15H2,(H,26,30)(H,27,28)(H,29,33);8-11H,4-7,12H2,1-3H3,(H,24,28)(H,25,26)(H,27,30);5-12H,1-4H3,(H,23,27)(H,24,25)(H,26,28);3-9H,10H2,1-2H3,(H,22,26)(H,23,27)(H,24,25);7-11H,3-6,20H2,1-2H3,(H,21,25)(H,22,23)(H,24,26)
InChIKeyZOWQGJPQMWCEQY-UHFFFAOYSA-N
XLogP21.86
TPSA733.00 Ų
H-Bond Donors19
H-Bond Acceptors39
Rotatable Bonds36
Heavy Atoms196
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002731.87
LogP ≤ 521.86
H-Bond Donors ≤ 519
H-Bond Acceptors ≤ 1039

Analyze 4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide?
The IUPAC name of 4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide (CID 162179916) is 4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide.
What is the SMILES notation for 4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide?
The canonical SMILES for 4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide is COc1cc2nc(-c3[nH]ncc3NC(=O)C3CCC(N)CC3)[nH]c2cc1OC.COc1cc2nc(-c3[nH]ncc3NC(=O)CS(=O)(=O)c3ccc(Cl)cc3)[nH]c2cc1OC.COc1cc2nc(-c3[nH]ncc3NC(=O)c3cc(CN4CCOCC4)c(C)o3)[nH]c2cc1OC.COc1ccc(C(C)(C)C)cc1C(=O)Nc1cn[nH]c1-c1nc2ccccc2[nH]1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cc(-c2ccccc2)no1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cccnc1Sc1ccc(Cl)cc1.
What is the InChIKey of 4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide?
The InChIKey is ZOWQGJPQMWCEQY-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H24ClN7O2S.C25H23N7O3.C23H26N6O5.C22H23N5O2.C20H18ClN5O5S.C19H24N6O3/c28-18-4-6-19(7-5-18)38-27-20(2-1-9-29-27)26(36)33-23-15-30-34-24(23)25-31-21-8-3-17(14-22(21)32-25)16-35-10-12-37-13-11-35;33-25(22-13-19(31-35-22)17-4-2-1-3-5-17)29-21-14-26-30-23(21)24-27-18-7-6-16(12-20(18)28-24)15-32-8-10-34-11-9-32;1-13-14(12-29-4-6-33-7-5-29)8-20(34-13)23(30)27-17-11-24-28-21(17)22-25-15-9-18(31-2)19(32-3)10-16(15)26-22;1-22(2,3)13-9-10-18(29-4)14(11-13)21(28)26-17-12-23-27-19(17)20-24-15-7-5-6-8-16(15)25-20;1-30-16-7-13-14(8-17(16)31-2)25-20(24-13)19-15(9-22-26-19)23-18(27)10-32(28,29)12-5-3-11(21)4-6-12;1-27-15-7-12-13(8-16(15)28-2)23-18(22-12)17-14(9-21-25-17)24-19(26)10-3-5-11(20)6-4-10/h1-9,14-15H,10-13,16H2,(H,30,34)(H,31,32)(H,33,36);1-7,12-14H,8-11,15H2,(H,26,30)(H,27,28)(H,29,33);8-11H,4-7,12H2,1-3H3,(H,24,28)(H,25,26)(H,27,30);5-12H,1-4H3,(H,23,27)(H,24,25)(H,26,28);3-9H,10H2,1-2H3,(H,22,26)(H,23,27)(H,24,25);7-11H,3-6,20H2,1-2H3,(H,21,25)(H,22,23)(H,24,26).
What are the key properties of 4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide?
4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide has a molecular weight of 2731.87 g/mol, XLogP of 21.86, 36 rotatable bonds, 19 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for 4-amino-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexane-1-carboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-tert-butyl-2-methoxybenzamide;2-(4-chlorophenyl)sulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-3-carboxamide;2-(4-chlorophenyl)sulfonyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-5-methyl-4-(morpholin-4-ylmethyl)furan-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenyl-1,2-oxazole-5-carboxamide is sourced from PubChem (CID 162179916), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).